NEW YORK ( TheStreet) -- A handful of stocks trading near $5 were poised to move on above-average volume during Wednesday's regular session.

Cyclacel Pharmaceuticals ( CYCC) jumped 12.5% to $2.70 after the company announced that a newly published study in clinical cancer research demonstrates potential for Cyclacel's Seliciclib in treating breast cancer resistant to hormone therapy. Selicicli is currently in phase 2 clinical trials. The 50-day average daily volume for Cyclacel is 7.4 million shares.

Achillion Pharmaceuticals ( ACHN) rose 4.6% to $2.50 after the company announced additional positive safety and efficacy results from its Phase 2 trial studying elvucitabine in patients infected with HIV. The 50-day average daily volume for Achillion Pharmaceuticals is 893,000 shares.

Netlist ( NLST) shot up 7.9% to $4.50 after it said it began volume shipments of its non-volatile cache memory product NetVault. The 50-day average daily volume for Netlist is 2.3 million shares.

Sequenom ( SQNM) edged 0.4% lower to $5.20 after the company announced the launch of its SensiGene fetal sex determination test.The 50-day average daily volume for Sequenom is 3.5 million shares.

-- Reported by Andrea Tse in New York

Check out all of Tuesday's high-volume, under-$10 stocks at the Dollar Store

>>See our new stock quote page.

Follow on Twitter and become a fan on Facebook.
Copyright 2009 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

If you liked this article you might like

Biotech Movers: Shire Rises on Encouraging Angioedema Results

Moleculin Biotech gets good verbal Ok from FDA which should cut time to Phase 1/2 trial down

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Here's Why Cyclacel Pharmaceuticals (CYCC) Stock Is Surging Today

Cyclacel Pharmaceuticals (CYCC) Stock Pops, H.C. Wainwright Bullish